Terms: = Prostate cancer AND CHD4, Mi2-BETA, 1108, ENSG00000111642, Mi-2b, DKFZp686E06161, Q14839 AND Diagnosis
3 results:
1. cancer Risk in 2621 Chinese Patients with Inflammatory Bowel Disease: A Population-based Cohort Study.
So J; Tang W; Leung WK; Li M; Lo FH; Wong MTL; Sze ASF; Leung CM; Tsang SWC; Shan EHS; Chan KH; Lam BCY; Hui AJ; Chow WH; Lam TY; Lam V; Lee TW; Lo HHH; Tang CM; Wong CL; Wu JCY; Chan FKL; Sung JJY; Harbord M; Ng SC
Inflamm Bowel Dis; 2017 Nov; 23(11):2061-2068. PubMed ID: 28991855
[TBL] [Abstract] [Full Text] [Related]
2. Prognostic utility of the cell cycle progression score generated from biopsy in men treated with prostatectomy.
Bishoff JT; Freedland SJ; Gerber L; Tennstedt P; Reid J; Welbourn W; Graefen M; Sangale Z; Tikishvili E; Park J; Younus A; Gutin A; Lanchbury JS; Sauter G; Brawer M; Stone S; Schlomm T
J Urol; 2014 Aug; 192(2):409-14. PubMed ID: 24508632
[TBL] [Abstract] [Full Text] [Related]
3. Predicting the outcome of prostate biopsy: comparison of a novel logistic regression-based model, the prostate cancer risk calculator, and prostate-specific antigen level alone.
Hernandez DJ; Han M; Humphreys EB; Mangold LA; Taneja SS; Childs SJ; Bartsch G; Partin AW
BJU Int; 2009 Mar; 103(5):609-14. PubMed ID: 19007374
[TBL] [Abstract] [Full Text] [Related]
